Publication

Frequency and determinants of disagreement and error in Gleason scores: a population-based study of prostate cancer

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Michael Goodman, Emory UniversityKevin C. Ward, Emory UniversityAdeboye O. Osunkoya, Emory UniversityMilton W. Datta, University of MinnesotaDaniel Luthringer, Cedars-Sinai Medical CenterAndrew N Young, Emory UniversityKaterina Marks, Emory UniversityVaunita Cohen, Emory UniversityJan C. Kennedy, Dekalb Medical CenterMichael J. Haber, Emory UniversityMahul B Amin, Cedars-Sinai Medical Center
Language
  • English
Date
  • 2012-09-15
Publisher
  • Wiley: 12 months
Publication Version
Copyright Statement
  • © 2012 Wiley Periodicals, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0270-4137
Volume
  • 72
Issue
  • 13
Start Page
  • 1389
End Page
  • 1398
Grant/Funding Information
  • This study was funded by the grant N01-PC- 32187 (PI Michael Goodman) from the National Cancer Institute’s SEER program
Abstract
  • Background To examine factors that affect accuracy and reliability of prostate cancer grade we compared Gleason scores documented in pathology reports and those assigned by urologic pathologists in a population-based study. Methods A stratified random sample of 318 prostate cancer cases diagnosed was selected to ensure representation of whites and African-Americans and to include facilities of various types. The slides borrowed from reporting facilities were scanned and the resulting digital images were re-reviewed by two urologic pathologists. If the two urologic pathologists disagreed, a third urologic pathologist was asked to help arrive at a final “gold standard” result. The agreements between reviewers and between the pathology reports and the “gold standard” were examined by calculating kappa statistics. The determinants of discordance in Gleason scores were evaluated using multivariate models with results expressed as odds ratios (OR) and 95% confidence intervals (CI). Results The kappa values (95% CI) reflecting agreement between the pathology reports and the “gold standard,” were 0.61 (95% CI: 0.54, 0.68) for biopsies, and 0.37 (0.23, 0.51) for prostatectomies. Sixty three percent of discordant biopsies and 72% of discordant prostatectomies showed only minimal differences. Using free standing laboratories as reference, the likelihood of discordance between pathology reports and expert-assigned biopsy Gleason scores was particularly elevated for small community hospitals (OR=2.98; 95% CI: 1.73, 5.14). Conclusions The level of agreement between pathology reports and expert review depends on the type of diagnosing facility, but may also depend on the level of expertise and specialization of individual pathologists.
Author Notes
  • Correspondence: Michael Goodman MD, MPH, Department of Epidemiology, Emory University Rollins School of Public Health, 1518 Clifton Road, NE, Atlanta GA 30322; Email: mgoodm2@sph.emory.edu
Keywords
Research Categories
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items